Interim data from the first 24 months of a CYPRESS clinical trial suggest that glasses with SightGlass Vision’s Diffusion Optics Technology reduce both axial length and cycloplegic SER progression in six- and seven-year-old children. A paper on the trial – titled “Two Year Effectiveness of a Novel Myopia Management Spectacle ...
Already an Eyewear Intelligence subscriber? Sign in here.
Buying a membership today will give you:
Or sign-up for a trial month for just 9,90€. To continue reading this article register now.